Activity value 66International Buyer&Supplier,Last transaction date:
2024-10-30
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for esvida pharma from 2023 to 2024.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2024, the company has completed 4 transactions, with a transaction quantity of 105970 and a transaction weight of 0.
YearTransactionsQuantityWeight
2023161034510
202441059700
Bill of lading data
<
1/15
>
Trade date
2024/10/30
B/L No.
306864060700
Suppliers
công ty cổ phần dược phẩm cpc1 hà nội
Buyers
esvida pharma
POLs
——
PODs
——
Supply area
Vietnam
Purchas area
Vietnam
Weight
——
Amount
4880.6
Hs code
30049099
Product tags
haljab premix
Product description
Thuốc uống ARGINIAFORTE 2000,hỗ trợ điều trị các bệnh về gan, TPC: L-arginine L-aspartate 200mg/ml, Lô sx: 021024, NSX:01.10.24, HD:30.09.27. Hộp 4vỉ x 5 ống x 10ml. HSX: CPC1HN. Mới 100%,#&VN
Expand
Trade date
2024/10/30
B/L No.
306864060700
Suppliers
công ty cổ phần dược phẩm cpc1 hà nội
Buyers
esvida pharma
POLs
——
PODs
——
Supply area
Vietnam
Purchas area
Vietnam
Weight
——
Amount
4911.65
Hs code
30049099
Product tags
haljab premix
Product description
Thuốc uống ARGINIAFORTE 2000,hỗ trợ điều trị các bệnh về gan, TPC: L-arginine L-aspartate 200mg/ml, Lô sx: 011024, NSX:01.10.24, HD:30.09.27. Hộp 2vỉ x 5 ống x 10ml. HSX: CPC1HN. Mới 100%,#&VN
Expand
Trade date
2024/10/21
B/L No.
306837333040
Suppliers
công ty cổ phần dược phẩm cpc1 hà nội
Buyers
esvida pharma
POLs
——
PODs
——
Supply area
Vietnam
Purchas area
Romania
Weight
——
Amount
1179.9
Hs code
30049099
Product tags
haljab premix
Product description
Thuốc uống ARGINIA FORTE 2000,hỗ trợ điều trị các bệnh về gan, TPC: L-arginine L-aspartate 200mg/ml, Lô sx: 011024, NSX:01.10.24, HD:30.09.27. Hộp 2vỉ x 5 ống x 10ml. HSX: CPC1HN. Mới 100%#&VN
Expand
Trade date
2024/10/21
B/L No.
306837333040
Suppliers
công ty cổ phần dược phẩm cpc1 hà nội
Buyers
esvida pharma
POLs
——
PODs
——
Supply area
Vietnam
Purchas area
Romania
Weight
——
Amount
1214.4
Hs code
30049099
Product tags
haljab premix
Product description
Thuốc uống ARGINIA FORTE 2000,hỗ trợ điều trị các bệnh về gan, TPC: L-arginine L-aspartate 200mg/ml, Lô sx: 021024, NSX:01.10.24, HD:30.09.27. Hộp 4vỉ x 5 ống x 10ml. HSX: CPC1HN. Mới 100%#&VN
Expand
Trade date
2023/10/19
B/L No.
jxentrajtk435
Suppliers
west coast pharmaceutical works ltd.
Buyers
esvida pharma
esvida pharma is International Buyer&Supplier,
and primarily engages in the import and export business of products such as liver,nutraceutical product,phospholipid.
According to the 52wmb.com global trade database, as of 2024-10-30, the company has completed 135 international trades,
with its main trading regions covering india,turkey,vietnam etc.
The core products include HS21069099,HS30049099 etc,
often transported via constanta,port bucharest, port bucuresti etc,
and its main trading partners are west coast pharmaceutical works ltd.,promega tekstil ürünleri sanayi ve ticaret ltd.şti.,công ty cổ phần dược phẩm cpc1 hà nội.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on esvida pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.